Zetagen Therapeutics to Present Preliminary Results from Phase 2 Clinical Trial Targeting Metastatic Breast Cancer to Bone at the 2025 San Antonio Breast Cancer Symposium | AFP.com
Zetagen Therapeutics to Present at SABCS Zetagen Therapeutics, a clinical-stage biopharmaceutical company, will present preliminary results from a Phase 2 clinical trial targeting metastat…